1. Home
  2. PESI vs PROK Comparison

PESI vs PROK Comparison

Compare PESI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

BUY

Current Price

$12.12

Market Cap

370.3M

Sector

Industrials

ML Signal

BUY

Logo ProKidney Corp.

PROK

ProKidney Corp.

BUY

Current Price

$1.39

Market Cap

359.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PESI
PROK
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
370.3M
359.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
PESI
PROK
Price
$12.12
$1.39
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
319.5K
★ 1.2M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.61
N/A
EPS
N/A
★ N/A
Revenue
$642,000.00
★ $893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$81.87
$7.83
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 1075.00
52 Week Low
$8.58
$1.30
52 Week High
$21.32
$3.48

Technical Indicators

Market Signals
Indicator
PESI
PROK
Relative Strength Index (RSI) 21.61 37.72
Support Level $9.58 $1.30
Resistance Level $12.97 $1.76
Average True Range (ATR) 0.68 0.11
MACD -0.25 -0.03
Stochastic Oscillator 1.51 19.78

Price Performance

Historical Comparison
PESI
PROK

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: